Sysmex CZ & SK
Menu

Sysmex Europe SE unveils revolutionary automated laboratory solution for CRC screening: FIT DX™ Series

2025/05/13 – Norderstedt, Germany

Sysmex Europe SE, a global leader in diagnostic solutions, announces the launch of its groundbreaking automated solution for colorectal cancer (CRC) screening. Expanding its FIT DX™ Series portfolio, Sysmex Europe introduces a new fully automated solution for stool analysis, addressing the critical need for efficiency and scalability in combating one of the world’s deadliest cancers.


Pioneering automation solutions for CRC screening

As a company committed to advancing early cancer detection and saving lives, this launch delivers a state-of-the-art automation solution for colorectal cancer, the second leading cause of cancer-related deaths globally. Early detection can improve survival rates to 90%, making efficient screening essential. The innovative solution combines FOB Gold® technology, with the SENTiFIT® 800 analyser (550 tests/hour) and Inpeco’s new FlexLab™ X Lab Automation system, resulting in a modular design that adapts to lab-specific requirements in terms of space, throughput and budget.

The system minimises hands-on time, reduces errors and maximises walk-away time through its input and storage modules, which streamline sample handling. Additionally, a mobile app enables laboratory staff to monitor and manage operations efficiently from a tablet, freeing up time for critical tasks. This streamlined and fully automated system is tailored to centralised CRC screening programs and high-volume laboratories, enhancing operational efficiency and convenience.

Carlos Martínez Pons, Head of Sysmex Life Science EMEA: "Following the success of CRC screening programmes worldwide, they are entering into a new phase of geographical expansion and widening of the target population. More people will progressively benefit from these screening programmes, but their complexity and sample volume will increase, getting more difficult to manage. As a response to these new challenges, we are proud to launch our fully automated solution for colorectal cancer screening. It is a groundbreaking addition to the FIT DXTM Series portfolio, which now allows us to provide a tailored solution for every screening programme, even the most ambitious ones. This innovation underscores Sysmex’s commitment to advancing early detection, improving CRC survival, and empowering laboratories to deliver better outcomes."

For more information about the FIT DXTM Series, please visit our website www.sysmex-europe.com/FITDXseries or contact us. 

About Sentinel Diagnostics (Sentinel CH. SpA) 

Sentinel Diagnostics (Sentinel CH. SpA) is an innovative company that through the development of its products contributes to the growth of scientific knowledge and the improvement of people's health in the diagnostic field. For more than 40 years, Sentinel Diagnostics, an Italian company based in Milan, has been developing and producing in vitro diagnostic devices for the most advanced Clinical Chemistry, Immunochemistry and Molecular Diagnostics platforms.  

For further information, please visit Sentinel's website: www.sentineldiagnostics.com

About Inpeco 

Inpeco is the global leader in Total Laboratory Automation. The company’s game-changing solutions combine open connectivity with full sample traceability to support secure test results and increase productivity in clinical laboratories around the world. To date, more than 2600 Inpeco systems have been shipped to 78 countries. Inpeco also provides automation for anatomical pathology labs and is developing solutions for blood banks and life sciences applications. The Group is headquartered in Novazzano, Switzerland, and operates a development and manufacturing facility in Italy, as well as sales and service offices in Europe and the United States. www.inpeco.com 

About Sysmex Europe SE 

Sysmex supports healthcare professionals around the world in lighting the way with diagnostics by providing a broad range of medical diagnostics products and solutions. In the fields of haematology, urinalysis, haemostasis, life science, flow cytometry, essential healthcare and now immunochemistry, we combine highly dependable, multi-functional and easy-to-operate instruments, a variety of reagents and software, plus reliable service and support. 

Sysmex Europe SE, located near Hamburg, Germany, is a subsidiary of the Sysmex Corporation from Kobe, Japan. From our Hamburg offices, we serve our affiliates, distributors and customers throughout Europe, the Middle East, and Africa (EMEA). For more information, visit www.sysmex-europe.com

SENTiFIT® and FOB GOLD® are trademarks in various jurisdictions, which are exclusively licensed to Sentinel CH. SpA. www.sentineldiagnostics.com 

Copyright © Sysmex Europe SE. All rights reserved.